← Pharmacy directory
503B pharmacy
BPI Labs
BPI Labs, LLC
Last reviewed 2026-06-13
Is BPI Labs legit?
BPI Labs is a 503B compounding pharmacy based in Florida, founded 2012. Below is what the public record shows: state licensing, FDA inspection and recall history, accreditations, and the telehealth clinics it ships for, each cited to a public source.
Regulatory record
- community-reported · 2026-04-25
- Production Ceased. Stopped tirzepatide production. Community-wide impact: every clinic using BPI as a partner had to scramble for alternates. Source ↗
Adverse actions are sourced from public agency records and reviewed on every editorial pass.
Where BPI Labs is licensed
Verified licensedLicensed, board action on fileVerified not licensedNot checked
Full state-by-state evidence ledger
State licensure, verified
- Delaware
- No license found — BPI Labs, LLC has only a Deficient Non-Resident-Pharmacy application (#APP-000089175) — no active DE license. State board lookup ↗ (verified 2026-07-13)
- Kansas
- Active · license #20-114365 · Pharmacy/Facility — BPI Labs, Largo FL. State board lookup ↗ (verified 2026-07-13)
- Nevada
- Active · license #OU00038 · Out Sourcing Facility (503B) — BPI Labs, LLC, Largo FL — registered as an Out Sourcing Facility + Wholesaler (503B pattern). State board lookup ↗ (verified 2026-07-13)
- Tennessee
- Licensed · license #00006635 · Pharmacy - Manufacturer/Wholesaler/Distributor — BPI Labs — registered under the Pharmacy-Manufacturer/Wholesaler category (the 503B pattern). State board lookup ↗ (verified 2026-07-13)
- New York
- Active · license #042009 · Outsource Facility - Not NYS (503B) — BPI Labs LLC, Largo FL — registered as an Outsource Facility + Manufacturer (the 503B pattern), not a resident pharmacy. State board lookup ↗ (verified 2026-07-12)
- Illinois
- Active · license #004003933 · Licensed Pharmacy — BPI Labs LLC, Largo FL. State board lookup ↗ (verified 2026-07-12)
- California
- No license found — No 'BPI' facility in the CA roster under any org type (incl. Nonresident Outsourcing Facility). State board lookup ↗ (verified 2026-07-12)
- Maine
- Active · license #MF30002251 · Prescription Drug Manufacturer — BPI Labs, LLC, Largo FL — holds an ACTIVE Prescription Drug Manufacturer license under the Board of Pharmacy regulator, NOT a mail-order pharmacy license (the 503B pattern also seen in VA/RI). An older manufacturer reg MF30001880 is canceled and an AL wholesaler reg failed to renew. State board lookup ↗ (verified 2026-07-12)
- Michigan
- Active · license #5301013511 · Pharmacy — Registered as BPI Labs, LLC, Largo, FL — the first Pharmacy-category license found for BPI Labs in any state sweep so far (TX/FL/IN/OK/NJ/OH all returned 0; VA found it only under a separate Outsourcing Facility category). State board lookup ↗ (verified 2026-07-12)
- Ohio
- No license found — Search for 'BPI' returned 0 records. State board lookup ↗ (verified 2026-07-12)
- Rhode Island
- Active · license #DIS04075 · Drug Manufacturer-Out of State — Registered as BPI Labs, LLC — a Drug Manufacturer-Out of State registration; a separate Pharmacy-category application shows 'Withdrawn From Pending'. State board lookup ↗ (verified 2026-07-12)
- New Jersey
- No license found — Search for 'BPI' returned no matching records. State board lookup ↗ (verified 2026-07-12)
- Oklahoma
- No license found — Search for 'BPI' returned no matching records. State board lookup ↗ (verified 2026-07-12)
- Virginia
- Active · license #0236000069 · Nonresident Outsourcing Facility — Registered as BPI Labs, LLC, Largo, FL, exp 03/31/2027 — a 503B outsourcing-facility registration, a different license category than the Non-resident Pharmacy category BPI Labs was not found under in TX/FL. State board lookup ↗ (verified 2026-07-12)
- Indiana
- No license found — Search for 'BPI' returned no Pharmacy-type license records. State board lookup ↗ (verified 2026-07-12)
- Florida
- Clear · license #PH32473 · Special Sterile Compounding Outsourcing Facility (Largo FL, home state) State board lookup ↗ (verified 2026-07-11)
- Texas
- No license found — Search 'BPI' returned no Texas records. State board lookup ↗ (verified 2026-07-11)
10 verified licensed · 7 verified not licensed. States not listed are unverified, not unlicensed — every row above reflects a real lookup against that state board's own portal on the date shown.
The file
- Type
- 503B · headquartered in Florida · founded 2012
- Licensed states
- 0 of 50 (unverified). The pharmacy advertises broad service but state licensure is not publicly documented.
- Accreditation
- FDA-registered 503B outsourcing facility (self-reported, unverified) · cGMP compliant per 21 CFR Part 210 and 211 (self-reported, unverified)
- API sourcing
- Not publicly disclosed.
Every line in this file cites a verifiable public source. Full citations at the bottom of the page.
FDA inspection history
- 2025-02-21
- Source PDF →
- 2025-03-20
- Source PDF →
Recalls, trailing 24 months
2024-12-12 · FDA recommended BPI Labs recall its unapproved Epinephrine Nasal Solution; per FDA's safety communication, the company had not removed the product from the market. FDA warned health care professionals not to use the BPI Labs epinephrine nasal solution.
Clinics that contract with this pharmacy
None on file.
Sources
- FDA: BPI Labs, LLC, Largo, FL - 483 issued 02/21/2025 (FDA Commissioner page). fda.gov · accessed 2026-06-13
- FDA Warning Letter to BPI Labs, LLC, ref. 699533, dated 03/20/2025 (unapproved/misbranded epinephrine nasal solution). fda.gov · accessed 2026-06-13
- FDA safety communication: warns health care professionals not to use epinephrine nasal solutions from BPI Labs and Endo USA; recall recommended. fda.gov · accessed 2026-06-13
- FDA: Compounding - Inspections, Recalls, and other Actions (lists BPI Labs actions including FMD-145 letter and Form 483). fda.gov · accessed 2026-06-13
- BPI Labs About Us page: legal name BPI Labs, LLC; HQ Largo, FL; founded 2012; subsidiary of Belcher Pharmaceuticals; self-described FDA-registered 503B outsourcing facility / cGMP. bpi-labs.com · accessed 2026-06-13
- American Pharmacy News: BPI Labs joins Empower Pharmacy in challenging Eli Lilly's tirzepatide patent (BPI Labs IPR petition, IPR2025-01346). americanpharmacynews.com · accessed 2026-06-13